Results 111 to 120 of about 15,109,420 (166)

Roles of mitochondrial complexes in non-alcoholic fatty liver disease. [PDF]

Front Mol Biosci
Wang K, Wang L, Ning J, Li D.
europepmc   +1 more source

Evidence Summary for Self-Management Education in Patients with Non-Alcoholic Fatty Liver Disease. [PDF]

Patient Prefer Adherence
Yang Y, Cao J, Zhang L, Liu J, Li M.
europepmc   +1 more source

Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials.gov Analysis

Omar E Hegazi,1,2 Samer O Alalalmeh,1,2 Moyad Shahwan,1,2 Ammar Abdulrahman Jairoun,3,4 Mansour M Alourfi,5,6 Ghfran Abdulrahman Bokhari,6 Abdullah Alkhattabi,6 Saeed Alsharif,7 Mohannad Abdulrahman Aljehani,8 Abdulmalik Mohammed Alsabban,9 Mohammad ...
Alkhattabi A, Alsabban AM, Alorfi NM, Ashour AM, Alourfi MM, Shahwan M, Jairoun AA, Alsharif S, Bokhari GA, AlMahmoud A, Hegazi OE, Alalalmeh SO, Almtrafi M, Alghamdi KM, Aljehani MA, Zakri YA   +15 more
core  

Temporal trend of serum vitamin profiles and the association with non-alcoholic fatty liver disease. [PDF]

Front Nutr
Hu C, Zhou J, Sun L, Chen Z.
europepmc   +1 more source

Associations between physical activity and dietary live microbe intake with non-alcoholic fatty liver disease: findings from the NHANES, 2007-2018. [PDF]

J Glob Health
Ding S, Hu X, Liu J.
europepmc   +1 more source

Significance of fatty acid metabolism regulators in the diagnosis and subtype classification in non-alcoholic fatty liver disease. [PDF]

Front Cell Dev Biol
Cao Z, Yu R, Cheng Y, Fei W, Chen Y.
europepmc   +1 more source

Dietary total antioxidant capacity and its dietary sources in association with non-alcoholic fatty liver disease: a case-control study. [PDF]

BMC Gastroenterol
Rohani FS, Emrani AS, Sasanfar B, Toorang F, Hosseinzadeh M.   +4 more
europepmc   +1 more source

Electroacupuncture in the treatment of non-alcoholic fatty liver disease: mechanistic insights and therapeutic potential. [PDF]

Front Med (Lausanne)
Wang Y, Zhang L.
europepmc   +1 more source

Identification of the critical immune-related drivers shared by non-alcoholic fatty liver disease and osteoporosis. [PDF]

Cell Mol Life Sci
Chang F, Ge S, Zhang M, Wu F, Cao F, Liu J, Lei M, Guo Z, Tang W, Chen M, Zhang L, Wang Y, Li Y, Yin P, Zhang L.   +14 more
europepmc   +1 more source

From Bench to Bedside: Multifunctional Nanoplatforms in the Fight Against Non-alcoholic Fatty Liver Disease. [PDF]

Int J Nanomedicine
Zhao Y, Wang L, Zhu S, Feng R, Zhang W.
europepmc   +1 more source